Impact of renin-angiotensin system blockade on the prognosis of acute coronary syndrome based on left ventricular ejection fraction
Journal
Revista espanola de cardiologia (English ed.)
Date Issued
2020-02
Author(s)
Raposeiras-Roubín, Sergio
Abu-Assi, Emad
Cespón-Fernández, María
Ibáñez, Borja
García-Ruiz, José Manuel
D'Ascenzo, Fabrizio
Simao Henriques, Jose Paulo
Saucedo, Jorge
Caneiro-Queija, Berenice
Cobas-Paz, Rafael
Muñoz-Pousa, Isabel
Wilton, Stephen B
González Juanatey, José Ramón
Kikkert, Wouter J
Núñez-Gil, Iván
Ariza-Solé, Albert
Song, Xiantao
Alexopoulos, Dimitrios
Liebetrau, Christoph
Kawaji, Tetsuma
Gaita, Fiorenzo
Huczek, Zenon
Nie, Shao-Ping
Yan, Yan
Fujii, Toshiharu
Correia, Luis
Kawashiri, Masa-Aki
Southern, Danielle
Alfonso, Emilio
Terol, Belén
Garay, Alberto
Zhang, Dongfeng
Chen, Yalei
Xanthopoulou, Ioanna
Osman, Neriman
Möllmann, Helge
Shiomi, Hiroki
Giordana, Francesca
Kowara, Michal
Filipiak, Krzysztof
Wang, Xiao
Fan, Jing-Yao
Ikari, Yuji
Nakahayshi, Takuya
Sakata, Kenji
Yamagishi, Masakazu
Íñiguez-Romo, Andrés
DOI
10.1016/j.rec.2019.02.012
Abstract
For patients with acute coronary syndrome (ACS) treated with percutaneous coronary intervention (PCI), it is unclear whether angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB) are associated with reduced mortality, particularly with preserved left ventricular ejection fraction (LVEF). The goal of this study was to determine the association between ACEI/ARB and mortality in ACS patients undergoing PCI, with and without reduced LVEF.